Clinical Trials on Early Systolic Blood Pressure Control Rate
Total 6206 results
-
SanofiRecruitingFabry's DiseaseUnited States
-
Bio Sidus SARecruiting
-
Helsinki University Central HospitalRecruitingEncephalitis | Traumatic Brain Injury | Hypoxia-Ischemia, Brain | Brain Hemorrhage | Stroke, Acute IschemicFinland
-
Weill Medical College of Cornell UniversityNational Heart, Lung, and Blood Institute (NHLBI)RecruitingMyocardial Fibrosis | Cardiomyopathies | Friedreich Ataxia | Cardiac HypertrophyUnited States
-
Capital Medical UniversityRecruitingCerebral Amyloid AngiopathyChina
-
Imperial College LondonImperial College Healthcare NHS TrustRecruitingStroke | Aortic Valve Stenosis | Silent Cerebral Infarct | Vascular Brain InjuryUnited Kingdom
-
Universitätsklinik für Neurologie, InnsbruckRecruitingParkinson Disease | Multiple System Atrophy, Parkinson Variant | Orthostatic; Hypotension, NeurogenicAustria
-
Hospital Clinico Universitario de SantiagoAlvaro Hermida (Co-IP); Susana Belen Bravo; Maria Teresa Cardoso; Cristobal Colon... and other collaboratorsRecruiting
-
Vanderbilt University Medical CenterRecruitingMultiple System Atrophy | Pure Autonomic Failure | Autonomic Failure | Orthostatic; Hypotension, Neurogenic | Orthostatic; Hypotension, ParkinsonismUnited States
-
Amicus TherapeuticsRecruiting
-
Assistance Publique - Hôpitaux de ParisRecruitingCadasil | Angiopathy; CerebralFrance
-
Amicus Therapeutics France SASCompletedFabry Disease | Anderson Fabry DiseaseFrance
-
University Health Network, TorontoOzmosis Research Inc.Completed
-
4D Molecular TherapeuticsActive, not recruiting
-
Bio Sidus SACompleted
-
TakedaCompleted
-
AVROBIOTerminatedFabry DiseaseUnited States, Australia, Brazil
-
National and Kapodistrian University of AthensCompletedFabry DiseaseGreece
-
Genzyme, a Sanofi CompanyCompleted
-
ProtalixChiesi Farmaceutici S.p.A.CompletedFabry DiseaseUnited States, Denmark, Belgium, United Kingdom, Norway, Italy, Czechia
-
ProtalixChiesi Farmaceutici S.p.A.CompletedFabry DiseaseUnited States, Spain, United Kingdom, Paraguay
-
Chiesi Farmaceutici S.p.A.Iqvia Pty Ltd; ProtalixCompletedFabry DiseaseUnited States, Belgium, Denmark, Italy, United Kingdom
-
University of California, IrvineMainz UniversityCompletedSturge - Weber Syndrome (SWS)United States
-
University of UtahGenzyme, a Sanofi CompanyCompletedFabry DiseaseUnited States
-
Amicus TherapeuticsCompletedFabry DiseaseUnited Kingdom, United States
-
Manchester University NHS Foundation TrustNorthern Care Alliance NHS Foundation TrustCompletedFabry DiseaseUnited Kingdom
-
Children's Hospital of Fudan UniversityFirst Affiliated Hospital, Sun Yat-Sen University; Wuhan Union Hospital, China and other collaboratorsWithdrawn
-
EmeraMedCompletedMultiple System Atrophy | Progressive Supranuclear PalsySlovenia
-
Johann Wolfgang Goethe University HospitalCompletedAtaxia TelangiectasiaGermany
-
ShireCompletedFabry DiseaseCanada, United States
-
ShireCompletedFabry DiseaseUnited States, United Kingdom, Australia, Czechia, Finland, Paraguay, Poland, Slovenia
-
ShireCompleted
-
ShireCompletedFabry DiseaseFinland, Sweden, Germany, Belgium, Czechia, Denmark
-
CENTOGENE GmbH RostockShire Human Genetic Therapies, Inc.CompletedFabry Disease | Cerebrovascular AccidentAustria, Croatia, France, Germany, Poland, Portugal, Georgia
-
University of NottinghamNational Institute for Health Research, United KingdomCompletedDysphagia Following Cerebral Infarction | Dysphagia Following Nontraumatic Intracerebral HemorrhageUnited Kingdom
-
National Institute of Mental Health (NIMH)TerminatedHIV-Associated Cognitive Motor ComplexUnited States
-
Amicus TherapeuticsApproved for marketingPhysician Initiated Expanded Access Request for Migalastat in Individual Patients With Fabry DiseaseFabry DiseaseUnited States, Australia
-
University College, LondonWithdrawnStroke | Acute Myocardial Infarction | Varicella Zoster | Transient Ischaemic Attack
-
Amicus TherapeuticsCompletedFabry DiseaseAustralia, Brazil
-
Amicus TherapeuticsCompletedFabry DiseaseUnited States
-
Amicus TherapeuticsTerminatedFabry DiseaseUnited Kingdom, United States, Australia, Brazil, France
-
Amicus TherapeuticsCompletedFabry DiseaseFrance, United Kingdom
-
Chiayi Christian HospitalSanofiUnknown
-
Merz Pharmaceuticals GmbHCompletedParkinson's Disease | Traumatic Brain Injury | Chronic Troublesome Sialorrhea | Post-strokeGermany, Poland
-
National Institute of Neurological Disorders and...CompletedFabry DiseaseUnited States
-
National Institute of Neurological Disorders and...Completed